Weebit Nano Valuation, page-43

I think it's less of an elephant in the room, the cell research patent belongs to Rice, but the companies method to reduce it's functional size and increase it's scaling ability would be WBT's IP. Pulling the patent would be bad for both companies.
(Based on my limited knowledge of patent law, the use of silicon in this way would be Rice's IP, but the method to scale/increase would become WBT's IP, as the research was done under WBT's guise, Rice would not be able to take it, and doing so would open up legal liability, if the patent is pulled, it's dead tech imo. [All subject to the agreement they've made ofc]) Someone correct me if I'm wrong.